GHA MEMBER PRESENTATION

Merck KGaA

Frankfurter Str. 250
64293 Darmstadt
Germany

www.merckgroup.com

YOUR CONTACT PARTNER

Joern-Peter Halle
Tel.: Tel.: +49 6151 72 8588
joern-peter.halle@merckgroup.com

Company / Organisation

Foundation: 1668
Founder: Friedrich Jacob Merck
Holder: Nearly 30% of the shares are traded in German DAX30-index / the Merck family controls slightly more than 70% of the company
Revenue: In 2019, Merck generated sales of € 16.2 billion in 66 countries
Management: Chair of the Executive Board and CEO of Merck: Belén Garijo
Employees: Around 58,000 employees (Dec 31, 2019)
Export portion: 29% of 2019 sales in Europe / 26% in North America / 35% in Asia Pacific / 6% in Latin America / 4% Middle East and Africa
Business fields:

Healthcare / Life Science / Electronics: From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere.

Brief Introduction:

Merck, a leading science and technology company, operates across healthcare, life science and electronics. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck generated sales of € 16.2 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD electronics.

SOLUTIONS | PRODUCTS | SERVICES: